Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening

ACS Chemical Biology

Volumn 8, Issue 4, 2013, Pages 778-788

  Dutta, Sanjib ^a   Chen, T Scott ^a   Keating, Amy E ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2 RELATED PROTEIN A1; LIGAND;

APOPTOSIS; ARTICLE; BINDING ASSAY; CLINICAL ASSESSMENT; DISSOCIATION; LEUKEMIA; LYMPHOMA; MELANOMA; NONHUMAN; PEPTIDE LIBRARY; POINT MUTATION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PROTO-ONCOGENE PROTEINS C-BCL-2;

MAMMALIA;

EID: 84876585589     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb300679a     Document Type: Article

References (48)

1. Leber, B., Lin, J., and Andrews, D. W. (2007) Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes Apoptosis 12, 897-911
2. Huang, D. C. and Strasser, A. (2000) BH3-Only proteins-essential initiators of apoptotic cell death Cell 103, 839-842
3. Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., and Huang, D. C. (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function Mol. Cell 17, 393-403
4. Cory, S., Huang, D. C., and Adams, J. M. (2003) The Bcl-2 family: roles in cell survival and oncogenesis Oncogene 22, 8590-8607
5. Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., Mc Henry, K. T., Pinchback, R. M., Ligon, A. H., Cho, Y. J., Haery, L., Greulich, H., Reich, M., Winckler, W., Lawrence, M. S., Weir, B. A., Tanaka, K. E., Chiang, D. Y., Bass, A. J., Loo, A., Hoffman, C., Prensner, J., Liefeld, T., Gao, Q., Yecies, D., Signoretti, S., Maher, E., Kaye, F. J., Sasaki, H., Tepper, J. E., Fletcher, J. A., Tabernero, J., Baselga, J., Tsao, M. S., Demichelis, F., Rubin, M. A., Janne, P. A., Daly, M. J., Nucera, C., Levine, R. L., Ebert, B. L., Gabriel, S., Rustgi, A. K., Antonescu, C. R., Ladanyi, M., Letai, A., Garraway, L. A., Loda, M., Beer, D. G., True, L. D., Okamoto, A., Pomeroy, S. L., Singer, S., Golub, T. R., Lander, E. S., Getz, G., Sellers, W. R., and Meyerson, M. (2010) The landscape of somatic copy-number alteration across human cancers Nature 463, 899-905
6. Kang, M. H. and Reynolds, C. P. (2009) Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy Clin. Cancer Res. 15, 1126-1132
7. Vogler, M. (2012) BCL2A1: the underdog in the BCL2 family Cell Death Differ. 19, 67-74
8. Lin, E. Y., Orlofsky, A., Berger, M. S., and Prystowsky, M. B. (1993) Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2 J. Immunol. 151, 1979-1988
9. Oberdoerffer, P., Kanellopoulou, C., Heissmeyer, V., Paeper, C., Borowski, C., Aifantis, I., Rao, A., and Rajewsky, K. (2005) Efficiency of RNA interference in the mouse hematopoietic system varies between cell types and developmental stages Mol. Cell. Biol. 25, 3896-3905
10. Beverly, L. J. and Varmus, H. E. (2009) MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family Oncogene 28, 1274-1279
11. Riker, A. I., Enkemann, S. A., Fodstad, O., Liu, S., Ren, S., Morris, C., Xi, Y., Howell, P., Metge, B., Samant, R. S., Shevde, L. A., Li, W., Eschrich, S., Daud, A., Ju, J., and Matta, J. (2008) The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis BMC Med. Genomics 1, 13
12. Lee, C. F., Ling, Z. Q., Zhao, T., Fang, S. H., Chang, W. C., Lee, S. C., and Lee, K. R. (2009) Genomic-wide analysis of lymphatic metastasis-Associated genes in human hepatocellular carcinoma World J. Gastroenterol. 15, 356-365
13. Senft, D., Berking, C., Graf, S. A., Kammerbauer, C., Ruzicka, T., and Besch, R. (2012) Selective induction of cell death in melanoma cell lines through targeting of Mcl-1 and A1 PLoS One 7, e30821
14. Piva, R., Pellegrino, E., Mattioli, M., Agnelli, L., Lombardi, L., Boccalatte, F., Costa, G., Ruggeri, B. A., Cheng, M., Chiarle, R., Palestro, G., Neri, A., and Inghirami, G. (2006) Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes J. Clin. Invest. 116, 3171-3182
15. Campone, M., Campion, L., Roche, H., Gouraud, W., Charbonnel, C., Magrangeas, F., Minvielle, S., Geneve, J., Martin, A. L., Bataille, R., and Jezequel, P. (2008) Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen Breast Cancer Res. Treat. 109, 491-501
16. Olsson, A., Norberg, M., Okvist, A., Derkow, K., Choudhury, A., Tobin, G., Celsing, F., Osterborg, A., Rosenquist, R., Jondal, M., and Osorio, L. M. (2007) Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia Br. J. Cancer 97, 769-777
17. Simmons, M. J., Fan, G., Zong, W. X., Degenhardt, K., White, E., and Gelinas, C. (2008) Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist Oncogene 27, 1421-1428
18. Ku, B., Liang, C., Jung, J. U., and Oh, B. H. (2011) Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX Cell Res. 21, 627-641
19. Werner, A. B., de Vries, E., Tait, S. W., Bontjer, I., and Borst, J. (2002) Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-Apoptotic Bak or Bax J. Biol. Chem. 277, 22781-22788
20. Willis, S. N., Chen, L., Dewson, G., Wei, A., Naik, E., Fletcher, J. I., Adams, J. M., and Huang, D. C. (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins Genes Dev. 19, 1294-1305
21. Zhai, D., Jin, C., Huang, Z., Satterthwait, A. C., and Reed, J. C. (2008) Differential regulation of Bax and Bak by anti-Apoptotic Bcl-2 family proteins Bcl-B and Mcl-1 J. Biol. Chem. 283, 9580-9586
22. Certo, M., Del Gaizo Moore, V., Nishino, M., Wei, G., Korsmeyer, S., Armstrong, S. A., and Letai, A. (2006) Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members Cancer Cell 9, 351-365
23. Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., Roberts, L., Tahir, S. K., Xiao, Y., Yang, X., Zhang, H., Fesik, S., Rosenberg, S. H., and Elmore, S. W. (2008) ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor Cancer Res. 68, 3421-3428
24. Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., Joseph, M. K., Kitada, S., Korsmeyer, S. J., Kunzer, A. R., Letai, A., Li, C., Mitten, M. J., Nettesheim, D. G., Ng, S., Nimmer, P. M., O'Connor, J. M., Oleksijew, A., Petros, A. M., Reed, J. C., Shen, W., Tahir, S. K., Thompson, C. B., Tomaselli, K. J., Wang, B., Wendt, M. D., Zhang, H., Fesik, S. W., and Rosenberg, S. H. (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours Nature 435, 677-681
25. Zhai, D., Jin, C., Satterthwait, A. C., and Reed, J. C. (2006) Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins Cell Death Differ. 13, 1419-1421
26. Brien, G., Debaud, A. L., Bickle, M., Trescol-Biemont, M. C., Moncorge, O., Colas, P., and Bonnefoy-Berard, N. (2011) Characterization of peptide aptamers targeting Bfl-1 anti-Apoptotic protein Biochemistry 50, 5120-5129
27. Herman, M. D., Nyman, T., Welin, M., Lehtio, L., Flodin, S., Tresaugues, L., Kotenyova, T., Flores, A., and Nordlund, P. (2008) Completing the family portrait of the anti-Apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim FEBS Lett. 582, 3590-3594
28. Smits, C., Czabotar, P. E., Hinds, M. G., and Day, C. L. (2008) Structural plasticity underpins promiscuous binding of the prosurvival protein A1 Structure 16, 818-829
29. Day, C. L., Chen, L., Richardson, S. J., Harrison, P. J., Huang, D. C., and Hinds, M. G. (2005) Solution structure of prosurvival Mcl-1 and characterization of its binding by proapoptotic BH3-only ligands J. Biol. Chem. 280, 4738-44
30. London, N., Gulla, S., Keating, A. E., and Schueler-Furman, O. (2012) In silico and in vitro elucidation of BH3 binding specificity toward Bcl-2 Biochemistry 51, 5841-5850
31. Dutta, S., Gulla, S., Chen, T. S., Fire, E., Grant, R. A., and Keating, A. E. (2010) Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL J. Mol. Biol. 398, 747-762
32. DeBartolo, J., Dutta, S., Reich, L., and Keating, A. E. (2012) Predictive Bcl-2 family binding models rooted in experiment or structure J. Mol. Biol. 422, 124-144
33. Eilers, P. H. and Goeman, J. J. (2004) Enhancing scatterplots with smoothed densities Bioinformatics 20, 623-628
34. Boder, E. T. and Wittrup, K. D. (1997) Yeast surface display for screening combinatorial polypeptide libraries Nat. Biotechnol. 15, 553-557
35. Gai, S. A. and Wittrup, K. D. (2007) Yeast surface display for protein engineering and characterization Curr. Opin. Struct. Biol. 17, 467-473
36. Tummino, P. J. and Copeland, R. A. (2008) Residence time of receptor-ligand complexes and its effect on biological function Biochemistry 47, 5481-5492
37. Liu, X., Dai, S., Zhu, Y., Marrack, P., and Kappler, J. W. (2003) The structure of a Bcl-xL/Bim fragment complex: implications for Bim function Immunity 19, 341-352
38. Fire, E., Gullá, S., Grant, R. A., and Keating, A. E. (2010) Mcl-1- Bim complexes accommodate surprising point mutations via minor structural changes Protein Sci. 19, 507-519
39. Lovell, S. C., Word, J. M., Richardson, J. S., and Richardson, D. C. (2000) The penultimate rotamer library Proteins 40, 389-408
40. Lee, E. F., Sadowsky, J. D., Smith, B. J., Czabotar, P. E., Peterson-Kaufman, K. J., Colman, P. M., Gellman, S. H., and Fairlie, W. D. (2009) High-resolution structural characterization of a helical alpha/beta-peptide foldamer bound to the anti-Apoptotic protein Bcl-xL Angew. Chem., Int. Ed. 48, 4318-4322
41. Hinds, M. G., Lackmann, M., Skea, G. L., Harrison, P. J., Huang, D. C., and Day, C. L. (2003) The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity EMBO J. 22, 1497-1507
42. Holm, L. and Rosenstrom, P. (2010) Dali server: conservation mapping in 3D Nucleic Acids Res. 38, W545-549
43. Chen, T. S., Palacios, H., and Keating, A. E. (2013) Structure-Based Redesign of the Binding Specificity of Anti-Apoptotic Bcl-x(L) J. Mol. Biol. 425, 171-185
44. Raymond, C. K., Pownder, T. A., and Sexson, S. L. (1999) General method for plasmid construction using homologous recombination Biotechniques 26 (134-138) 140-141
45. Chao, G., Lau, W. L., Hackel, B. J., Sazinsky, S. L., Lippow, S. M., and Wittrup, K. D. (2006) Isolating and engineering human antibodies using yeast surface display Nat. Protoc. 1, 755-768
46. O'Shannessy, D. J., Brigham-Burke, M., Soneson, K. K., Hensley, P., and Brooks, I. (1993) Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods Anal. Biochem. 212, 457-468
47. Cushing, P. R., Fellows, A., Villone, D., Boisguerin, P., and Madden, D. R. (2008) The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling Biochemistry 47, 10084-10098
48. Roehrl, M. H., Wang, J. Y., and Wagner, G. (2004) A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein-protein interactions by fluorescence polarization Biochemistry 43, 16056-16066